Employees Retirement System of Texas’s Aimmune Therapeutics AIMT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | – | Sell |
-194,804
| Closed | -$6.71M | – | 756 |
|
|
2020
Q3 | $6.71M | Hold |
194,804
| – | – | 0.1% | 220 |
|
|
2020
Q2 | $3.25M | Hold |
194,804
| – | – | 0.05% | 363 |
|
|
2020
Q1 | $2.81M | Hold |
194,804
| – | – | 0.05% | 333 |
|
|
2019
Q4 | $6.52M | Hold |
194,804
| – | – | 0.1% | 238 |
|
|
2019
Q3 | $4.08M | Hold |
194,804
| – | – | 0.06% | 343 |
|
|
2019
Q2 | $4.06M | Hold |
194,804
| – | – | 0.06% | 352 |
|
|
2019
Q1 | $4.35M | Hold |
194,804
| – | – | 0.07% | 353 |
|
|
2018
Q4 | $4.66M | Hold |
194,804
| – | – | 0.07% | 310 |
|
|
2018
Q3 | $5.31M | Hold |
194,804
| – | – | 0.07% | 331 |
|
|
2018
Q2 | $5.24M | Hold |
194,804
| – | – | 0.07% | 338 |
|
|
2018
Q1 | $6.2M | Hold |
194,804
| – | – | 0.08% | 288 |
|
|
2017
Q4 | $7.37M | Hold |
194,804
| – | – | 0.09% | 261 |
|
|
2017
Q3 | $4.83M | Hold |
194,804
| – | – | 0.06% | 383 |
|
|
2017
Q2 | $4M | Hold |
194,804
| – | – | 0.05% | 437 |
|
|
2017
Q1 | $4.23M | Hold |
194,804
| – | – | 0.06% | 417 |
|
|
2016
Q4 | $3.98M | Buy |
+194,804
| New | +$3.98M | 0.05% | 420 |
|
Employees Retirement System of Texas's AIMT Position: Q4 2020 in Review
Employees Retirement System of Texas sold out of Aimmune Therapeutics (AIMT) in Q4 2020, closing a stake of 194,804 shares — an estimated $6.71M sold.
Employees Retirement System of Texas first reported a position in AIMT in Q4 2016 and held it in 16 quarters. The position peaked at $7.37M in Q4 2017. 0 funds tracked by Wall St. Rank hold AIMT as of Q4 2020.
- Employees Retirement System of Texas reported no remaining Aimmune Therapeutics position as of Q4 2020 after selling out during the quarter.
- Employees Retirement System of Texas sold 194,804 Aimmune Therapeutics shares in Q4 2020, an estimated $6.71M.
- Employees Retirement System of Texas first reported a position in Aimmune Therapeutics in Q4 2016 and held it in 16 quarters.
- Employees Retirement System of Texas's Aimmune Therapeutics position peaked at $7.37M in Q4 2017.
- 0 funds tracked by Wall St. Rank held Aimmune Therapeutics as of Q4 2020.
Based on Employees Retirement System of Texas's 13F filing for Q4 2020, filed 11 Feb 2021.